Vaccines and autism: Evidence does not support a causal association

Clinical Pharmacology and Therapeutics

Volumn 82, Issue 6, 2007, Pages 756-759

  DeStefano, F ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; THIOMERSAL;

ANIMAL BEHAVIOR; AUTISM; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEALTH EDUCATION; HEALTH MAINTENANCE ORGANIZATION; HUMAN; IMMUNIZATION; NEUROTOXICITY; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; VACCINATION; VIRUS STRAIN;

AUTISTIC DISORDER; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DENMARK; EPIDEMIOLOGIC STUDIES; EVIDENCE-BASED MEDICINE; HUMANS; INFANT, NEWBORN; MEASLES-MUMPS-RUBELLA VACCINE; MERCURY COMPOUNDS; PRESERVATIVES, PHARMACEUTICAL; THIMEROSAL; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 36148943197     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100407     Document Type: Review

References (33)

1. Bauman, M. & Kemper, T. Neuroanatomic observations of the brain in autism. In The Neurobiology of Autism (eds. Bauman, M., Kemper, T.) 119-145 (Johns Hopkins Univ. Press, Baltimore, 1997).
2. Wakefield, A.J. et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351, 637-641 (1998).
3. Kawashimi, H., Takayuki, M., Kashiwagi, Y., Takekuma, K., Akinori, H. & Wakefield, A. Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig. Dis. Sci. 45, 723-729 (2000).
4. Uhlmann, V. et al. Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol. Pathol. 55, 34-90 (2002).
5. D'Souza, Y., Fombonne, E. & Ward, B.J. No evidence of persisting measles virus in peripheral blood mononuclear cells from children with autism spectrum disorder. Pediatrics 118, 1664-1675 (2006).
6. Fombonne, E. & Chakrabarti, S. No evidence for a new variant of measles-mumps-rubella induced autism. Pediatrics 108, E58 (2001).
7. Richler, J. et al. Is there a 'regressive phenotype' of autism spectrum disorder associated with the measles-mumps-rubella vaccine? A CPEA Study. J. Autism Dev. Disord. 36, 299-316 (2006).
8. Taylor, B. et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 353, 2026-2029 (1999).
9. Chen, W., Landau, S., Sham, P. & Fombonne, E. No evidence for links between autism MMR and measles virus. Psychol. Med. 34, 543-553 (2004).
10. Kaye, J.A., del Mar Melero-Montes, M. & Jick, H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 322, 460-463 (2001).
11. Dales, L., Hammer, S.J. & Smith, N.J. Time trends in autism and in MMR immunization coverage in California. JAMA 285, 1183-1185 (2001).
12. Honda, H., Shimizu, Y. & Rutter, M. No effect of MMR withdrawal on the incidence of autism: a total population study. J. Child Psychol. Psychiatry 46, 572-579 (2005).
13. Uchiyama, T., Kurosawa, M. & Inaba, Y. MMR-vaccine and regression in autism spectrum disorders: negative results presented from Japan. J. Autism Dev. Disord. 37, 210-217 (2007).
14. Fombonne, E., Zakarian, R., Bennett, A., Meng, L. & McLean-Heywood, D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 118, e139-e150 (2006).
15. Madsen, K.M. et al. A population-based study of measles, mumps, and rubella vaccination and autism. N. Engl. J. Med. 347, 1477-1482 (2002).
16. DeStefano, F., Karapurkar, T., Thompson, W.W., Yeargin-Allsopp, M. & Boyle, C. Age at first measles-mumps-rubella vaccination in children with autism and school-matched controls: a population-based study in metropolitan Atlanta. Pediatrics 113, 259-266 (2004).
17. Smeeth, L. et al. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 364, 963-969 (2004).
18. Ferriman, A. MP raises new allegations against Andrew Wakefield. BMJ 328, 726 (2004).
19. Murch, S. A statement by Dr Simon Murch. Allegations concerning our 1998 study. Lancet 363, 821-822 (2004).
20. Immunization Safety Review Committee. Immunization Safety Review. Vaccines and Autism Board of Health Promotion and Disease Prevention, Institute of Medicine (National Academy Press, Washington, DC, 2004).
21. Ball, L.K., Ball, R. & Pratt, R.D. An assessment of thimerosal use in childhood vaccines. Pediatrics 107, 1147-1154 (2001).
22. Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS). Pediatrics 104, 568-569 (1999).
23. Grandjean, P. et al. Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years. Am. J. Epidemiol. 150, 301-305 (1999).
24. Davidson, P.W., Kost, J., Myers, G.J., Cox, C., Clarkson, T.W. & Shamlaye, C.F. Methylmercury and neurodevelopment: reanalysis of the Seychelles Child Development Study outcomes at 66 months of age. JAMA 285, 1291-1293 (2001).
25. Pichichero, M.E., Cernichiari, E., Lopreiato, J. & Treanor, J. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: a descriptive study. Lancet 360, 1737-1741 (2002).
26. Burbacher, T.M., Shen, D.D., Liberato, N., Grant, K.S., Cernichiari, E. & Clarkson, T. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ. Health Perspect. 113, 1015-1021 (2005).
27. Hornig, M., Chian, D. & Lipkin, W.I. Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol. Psychiatry 9, 833-845 (2004).
28. Baskin, D.S., Ngo, H. & Didenko, V.V. Thimerosal induces DNA breaks, caspase-3 activation, membrane damage, and cell death in cultured human neurons and fibroblasts. Toxicol. Sci. 74, 361-368 (2003).
29. Geier, M.R. & Geier, D.A. Thimerosal in childhood vaccines, neurodevelopmental disorders, and heart disease in the United States. J. Am. Phys. Surg. 8, 6-11 (2003).
30. Stehr-Green, P., Tull, P., Stellfeld, M., Mortenson, P. & Simpson, D. Autism and thimerosal-containing vaccines: lack of consistent evidence for an association. Am. J. Prev. Med. 25, 101-106 (2003).
31. Hviid, A., Stellfeld, M., Wohlfahrt, J. & Melbye, M. Association between thimerosal-containing vaccine and autism. JAMA 290, 1763-1766 (2003).
32. Andrews, N., Miller, E., Grant, A., Stowe, J., Osborne, V. & Taylor, B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics 114, 584-591 (2004).
33. Verstraeten, T. et al. Safety of thimerosal-containing vaccines: a twophased study of computerized health maintenance organization databases. Pediatrics 112, 1039-1048 (2003).